De novo heterozygous pathogenic variants in DNM1L have been previously reported to be associated with neonatal or infantile-onset encephalopathy characterized by hypotonia, developmental delay and refractory epilepsy. The gene discussed is DNM1L; the disease is Global developmental delay.